Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/120634

Beta release

Statistics of Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0600
2024-0700
2024-0800